Increasing our understanding of the pathogenesis of ACC may provide potential treatment targets, including 9-cisRA [15], miRNAs [14], and topoisomerase 2-alpha (TOP2A) [16]. This evidence concerns the gene TOP2A and adrenal cortex carcinoma.